In vitro synthesis of IgM and IgM rheumatoid factor in seronegative arthritides. 1984

G S Alarcón, and W J Koopman, and R E Schrohenloher

In vitro patterns of IgM and IgM rheumatoid factor (RF) synthesis exhibited by peripheral blood B cells (MNL) obtained from healthy individuals as well as patients with seropositive and seronegative rheumatoid arthritis (RA) have been previously examined. The present study was performed in a group of patients with non-rheumatoid seronegative arthritis (SNA) in order to compare patterns of in vitro IgM and IgM RF synthesis to that previously observed with seropositive and seronegative RA. Eighteen patients with SNA (4 ankylosing spondylitis, 10 psoriatic arthritis, and 4 unclassified variant disease) were studied as well as 18 healthy adult controls. Spontaneous release of IgM RF by MNL was not observed in SNA or controls. In contrast, IgM RF was detected in pokeweed mitogen (PWM)-stimulated MNL culture supernatants from 9/18 SNA (mean +/- SD = 17.0 +/- 9.9 ng/10(6) cells), and 10/18 normal controls (16.7 +/- 9.9 ng). Synthesis of IgM by PWM-stimulated MNL from SNA (2062 +/- 1200 ng) was significantly less than observed with MNL from controls (4093 +/- 1896 ng) (P less than 0.001). There were no differences among the various SNA subsets with regards to the levels of IgM and IgM RF produced either spontaneously or after PWM stimulation. IgM RF constituted a small fraction of the total IgM in SNA and normals (0.9% and 0.5%, respectively). This is clearly distinct from seropositive RA in which we have previously established that IgM RF constitutes a substantial fraction of the total IgM (10.7%) (P less than 0.01). IgM and IgM RF production did not appear to be significantly influenced by immunosuppressive medication.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides

Related Publications

G S Alarcón, and W J Koopman, and R E Schrohenloher
January 1991, Rheumatology international,
G S Alarcón, and W J Koopman, and R E Schrohenloher
September 1980, Arthritis and rheumatism,
G S Alarcón, and W J Koopman, and R E Schrohenloher
April 1983, The Journal of rheumatology,
G S Alarcón, and W J Koopman, and R E Schrohenloher
September 1993, The Journal of rheumatology,
G S Alarcón, and W J Koopman, and R E Schrohenloher
February 1980, Annals of the rheumatic diseases,
G S Alarcón, and W J Koopman, and R E Schrohenloher
August 1980, Journal of immunology (Baltimore, Md. : 1950),
G S Alarcón, and W J Koopman, and R E Schrohenloher
January 1982, Rheumatology international,
G S Alarcón, and W J Koopman, and R E Schrohenloher
March 1982, Lancet (London, England),
Copied contents to your clipboard!